KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Currently predicting for Mon, 29 Apr 2024

Trading levels for CLRB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.18 5.06 %
R2 3.13 3.29 %
R1 3.10 2.20 %
Current price: 3.03
Support S1 2.99 -1.32 %
S2 2.96 -2.41 %
S3 2.90 -4.18 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.78 24.75 %
R2 3.50 15.51 %
R1 3.49 15.18 %
Current price 3.03
Support S1 3.02 -0.330%
S2 0 .
S3 0 .

CLRB Predictions History

7 years ago
Kaiser.Clipston.3200 predicted that CLRB for 2017-02-23 is going $2.18 (-11.02%)

Rank:

7 years ago
turki predicted that CLRB for 2017-02-21 is going $2.35 (-2.89%)

Rank:

7 years ago
JS predicted that CLRB for 2017-02-21 is going $2.38 (-1.65%)

7 years ago
Ron.Boutwell.1883 predicted that CLRB for 2017-02-15 is going $2.25 (-9.64%)

Rank:

7 years ago
JS predicted that CLRB for 2017-02-15 is going $2.40 (-3.61%)

7 years ago
Ethan.Carpenter.1142 predicted that CLRB for 2016-09-30 is going $3.23 (19.19%)

Rank:

7 years ago
JS predicted that CLRB for 2016-09-30 is going $3.17 (16.97%)

7 years ago
PumpTheseNumbers predicted that CLRB for 2016-09-30 is going $2.71 (0.00%)

7 years ago
Steven.Geringer.277 predicted that CLRB for 2016-06-17 is going $3.95 (7.34%)

Rank:
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT